The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>
Andrea Visentin(University of Padua), Gilad Itchaki(Meir Medical Center), Christos Demosthenous(G. Papanikolaou General Hospital), Julio Delgado(Departament de Salut), Yervand Hakobyan, Massimo Gentile(Azienda Ospedaliera di Cosenza), Yair Herishanu(Tel Aviv University), Lorenzo De Paoli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Rosa Collado(Hospital General Universitario De Valencia), Henrik Frederiksen(University of Southern Denmark), David Allsup(University of Leeds), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Rocío García‐Serra(Hospital General Universitario De Valencia), Lydia Scarfò(IRCCS Ospedale San Raffaele), Salma Elashwah(Mansoura University), Panagiotis Baliakas(Uppsala University), Darko Antić(University of Belgrade), Lucia Farina(Fondazione IRCCS Istituto Nazionale dei Tumori), Juan Gonzalo Correa(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), José‐Ángel Hernández‐Rivas(Hospital Universitario Infanta Leonor), Michael Doubek(Central European Institute of Technology), Anargyros Kapetanakis(Centre for Research and Technology Hellas), Idanna Innocenti(Università Cattolica del Sacro Cuore), Mónica Baile(Instituto de Investigación Biomédica de Salamanca), Alicia Enrico(Hospital Italiano La Plata), Alejandro Alonso Cabrero(Hospital Universitario de La Princesa), Mark Catherwood(University of Ulster), Dimitra Chamou(Centre for Research and Technology Hellas), Blanca Espinet(Hospital Del Mar), Carolina Cuéllar‐García(Hospital Terrassa), Moritz Fürstenau(University of Cologne), Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), Eva Gimeno(Hospital Del Mar), Maria Rosaria De Paolis(Istituto Nazionale di Fisica Nucleare, Sezione di Lecce), Sofia Chatzileontiadou(AHEPA University Hospital), Raúl Córdoba(Hospital Universitario Fundación Jiménez Díaz), Maria Dimou(National and Kapodistrian University of Athens), Eva Minga(Centre for Research and Technology Hellas), Martin Andres(University of Bern), Maria Efstathopoulou(Mansoura University), José A. García‐Marco(Hospital Universitario Puerta de Hierro Majadahonda), Tobias Herold(German Cancer Research Center), Andreas Glenthøj(University of Copenhagen), Barbara Eichhorst(University of Cologne), Sotiria Besikli‐Dimou(Centre for Research and Technology Hellas), Angela Ferrari(Santa Maria Nuova Hospital), Dominique Bron, Myriam Foglietta(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), David Donaldson(Endometriosis UK), Georgios Karakatsoulis(University of Ioannina)
Cited by 21
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2018|907